Jane Street »

Arrivent Biopharma shares owned by Jane Street

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Jane Street

Quarter filed Position value Share count Share price at filing
2024-09-30 $250k 11k 23.50
2024-06-30 $284k 15k 18.55
2024-03-31 $660k 37k 17.86

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Spdr Gold Tr Gold Shs (GLD)
Advanced Micro Devices Call Option (AMD)
Pdd Holdings Sponsored Ads Put Option (PDD)
Broadcom Put Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Jane Street

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Octagon Capital Advisors
BlackRock
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Geode Capital Management
Cormorant Asset Management
Perceptive Advisors
Northern Trust

View all funds holding Arrivent Biopharma